Psychedelics and Their Potential to Treat Psychiatric and Inflammatory Disease

Charles D. Nichols, PhD
Professor of Pharmacology
August 18, 2021 11:00 am
Location: Via Zoom

For more information or program materials email Charles D. Nichols, PhD at cnich1@lsuhsc.edu

To gain knowledge and understanding of:

  1. Serotonin, 5-HT2A receptor pharmacology, and their relationship to psychedelic drug action;
  2. The molecular effects of 5-HT2A receptor activation in the brain;
  3. Psychedelics to treat depression in humans, and development of rodent models to study mechanisms; and
  4. Psychedelics as anti-inflammatories in rodent models of human disease and their therapeutic potential for clinical use.



Accreditation: The Louisiana State University School of Medicine, New Orleans is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement: The Louisiana State University School of Medicine, New Orleans designates this live activity for a maximum 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.